| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Outreach Services is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Family Healthcare in SWVA. Medical Clinics in Bristol, Tazewell, Saltvillle, Meadowview, Virginia. Primary, Behavioral, Pediatric, Optometry, Dental
AOS Research Inc is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dinatec is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.